Hangaishi M, Ishizaka N, Aizawa T, Kurihara Y, Taguchi J, Nagai R, Kimura S, Ohno M
Department of Cardiovascular Medicine, University of Tokyo, Graduate School of Medicine, Hongo 7-3-1, Bunkyo-ku, Tokyo, 113-8655, Japan.
Biochem Biophys Res Commun. 2000 Dec 20;279(2):582-8. doi: 10.1006/bbrc.2000.3973.
Enhanced production of reactive oxygen species plays a role in myocardial injury following ischemia/reperfusion. Heme oxygenase-1 (HO-1) is a heme-catabolizing enzyme that is induced by and acts against oxidant-induced tissue injury. We examined whether HO-1 expression was regulated following ischemia and reperfusion in the rat heart. HO-1 expression increased as early as 24 h after reperfusion. Strong HO-1 expression was seen in monocytes/macrophages and myofibroblasts. Next, we examined whether the induction of HO-1 could ameliorate cardiac injury following ischemia/reperfusion. Intraperitoneal hemin injection (30 mg/kg/day) for 2 days prior to the operation resulted in an about 2.8-fold increase in HO-1 expression in the rat heart. Hemin treatment significantly decreased infarct area (6 +/- 2%) compared to the control (21 +/- 2%), which was reversed by the coadministration of an HO inhibitor in a dose-dependent manner. Our data suggest that induction of HO-1 can reduce the cardiac injury in vivo following ischemia/reperfusion.
活性氧的产生增加在缺血/再灌注后的心肌损伤中起作用。血红素加氧酶-1(HO-1)是一种血红素分解酶,可被氧化剂诱导并对抗其诱导的组织损伤。我们研究了大鼠心脏缺血再灌注后HO-1表达是否受到调节。再灌注后24小时,HO-1表达就开始增加。在单核细胞/巨噬细胞和成肌纤维细胞中可见强烈的HO-1表达。接下来,我们研究了HO-1的诱导是否能改善缺血/再灌注后的心脏损伤。手术前2天腹腔注射血红素(30mg/kg/天)导致大鼠心脏中HO-1表达增加约2.8倍。与对照组(21±2%)相比,血红素治疗显著降低了梗死面积(6±2%),HO抑制剂的共同给药以剂量依赖的方式逆转了这一结果。我们的数据表明,HO-1的诱导可以减轻体内缺血/再灌注后的心脏损伤。